Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Amphastar Pharmaceuticals (AMPH) EBT Margin: 2012-2024

Historic EBT Margin for Amphastar Pharmaceuticals (AMPH) over the last 13 years, with Dec 2024 value amounting to 26.66%.

  • Amphastar Pharmaceuticals' EBT Margin fell 1372.00% to 11.21% in Q3 2025 from the same period last year, while for Sep 2025 it was 19.51%, marking a year-over-year decrease of 782.00%. This contributed to the annual value of 26.66% for FY2024, which is 157.00% down from last year.
  • Amphastar Pharmaceuticals' EBT Margin amounted to 26.66% in FY2024, which was down 5.55% from 28.23% recorded in FY2023.
  • In the past 5 years, Amphastar Pharmaceuticals' EBT Margin ranged from a high of 28.23% in FY2023 and a low of 1.33% during FY2020.
  • For the 3-year period, Amphastar Pharmaceuticals' EBT Margin averaged around 26.80%, with its median value being 26.66% (2024).
  • Its EBT Margin has fluctuated over the past 5 years, first plummeted by 2,259bps in 2020, then soared by 1,789bps in 2021.
  • Over the past 5 years, Amphastar Pharmaceuticals' EBT Margin (Yearly) stood at 1.33% in 2020, then spiked by 1,789bps to 19.22% in 2021, then soared by 627bps to 25.49% in 2022, then spiked by 274bps to 28.23% in 2023, then tumbled by 157bps to 26.66% in 2024.